Literature DB >> 32895861

Variability in bone-seeking tracers and imaging protocols for the diagnosis of cardiac amyloidosis: The more the merrier?

Michal Weiler-Sagie1, Simona Ben-Haim2,3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32895861     DOI： 10.1007/s12350-020-02330-x

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  6 in total

1.  Early Phase 99Tc-HMDP Scintigraphy for the Diagnosis and Typing of Cardiac Amyloidosis.

Authors:  Arnault Galat; Axel Van der Gucht; Aziz Guellich; Diane Bodez; Anne-Ségolène Cottereau; Soulef Guendouz; Luc Hittinger; Jean-Luc Dubois-Randé; Violaine Plante-Bordeneuve; Emmanuel Itti; Michel Meignan; Thibaud Damy; Jean Rosso
Journal:  JACC Cardiovasc Imaging       Date:  2016-07-13

2.  Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.

Authors:  G Subramanian; J G McAfee; R J Blair; F A Kallfelz; F D Thomas
Journal:  J Nucl Med       Date:  1975-08       Impact factor: 10.057

3.  Efficient 1-Hour Technetium-99 m Pyrophosphate Imaging Protocol for the Diagnosis of Transthyretin Cardiac Amyloidosis.

Authors:  Ahmad Masri; Syed Bukhari; Shahzad Ahmad; Ricardo Nieves; Yvonne S Eisele; William Follansbee; Amy Brownell; Timothy C Wong; Erik Schelbert; Prem Soman
Journal:  Circ Cardiovasc Imaging       Date:  2020-02-17       Impact factor: 7.792

4.  Diphosphonate bone scanning agents--current concepts.

Authors:  I Fogelman
Journal:  Eur J Nucl Med       Date:  1982

5.  Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis.

Authors:  Patrick Martineau; Vincent Finnerty; Geneviève Giraldeau; Sébastien Authier; Francois Harel; Matthieu Pelletier-Galarneau
Journal:  J Nucl Cardiol       Date:  2019-03-04       Impact factor: 5.952

6.  Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation.

Authors:  Claire Cuscaden; Stuart C Ramsay; Sandhir Prasad; Bruce Goodwin; Jye Smith
Journal:  J Nucl Cardiol       Date:  2020-05-08       Impact factor: 5.952
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.